A Glimpse of Revolution Medicines's Earnings Potential

Revolution Medicines RVMD is gearing up to announce its quarterly earnings on Wednesday, 2025-05-07. Here’s a quick overview of what investors should know before the release.

Analysts are estimating that Revolution Medicines will report an earnings per share (EPS) of $-1.05.

Anticipation surrounds Revolution Medicines’s announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Earnings History Snapshot

In the previous earnings release, the company missed EPS by $0.16, leading to a 3.51% drop in the share price the following trading session.

Here’s a look at Revolution Medicines’s past performance and the resulting price change:

Performance of Revolution Medicines Shares

Shares of Revolution Medicines were trading at $39.795 as of May 05. Over the last 52-week period, shares are up 3.24%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Revolution Medicines visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.